Status:
COMPLETED
Access Creation for Hemodialysis: Association With Structural Changes of the Heart
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Kidney Foundation of Canada
Conditions:
Arteriovenous Fistula
Arteriovenous Graft
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine if the creation of a fistula or a graft plays a role in the development of heart disease for patients undergoing hemodialysis
Detailed Description
Patients with end stage renal disease are at 18-20 times greater risk of dying from cardiovascular disease as the general population. Both traditional and non-traditional cardiovascular risk factors a...
Eligibility Criteria
Inclusion
- 1)Hemodialysis 2)high risk for heart failure (DM, age\>50, and/or systolic dysfunction) 3) first arteriovenous fistula/graft 4) informed consent 5) technically adequate echocardiogram 6) stable hgb(\>100) 7) stable mineral metabolism (normal calcium, phosphate \<2.1mmol/L, PTH\>50pmol/L)
Exclusion
- 1)Expected survival \<1 year 2) Expected to get a living donor transplant in one year 3)primary access failure 4) ARF
Key Trial Info
Start Date :
April 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00368147
Start Date
April 1 2002
End Date
February 1 2007
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Heatlh Network
Toronto, Ontario, Canada, M5G 2C4